The balloon-expandable stents market is experiencing significant growth driven by advancements in cardiovascular treatments and the rising prevalence of coronary artery disease. Balloon-expandable stents are widely used in angioplasty procedures due to their precision in placement and ability to restore blood flow efficiently. These stents, primarily made of metallic materials such as stainless steel and cobalt-chromium, provide structural support to narrowed arteries, ensuring improved patient outcomes. The market is expanding due to an increasing geriatric population, a higher incidence of lifestyle-related diseases, and continuous technological advancements in stent design. Recent developments include drug-eluting balloon-expandable stents that reduce restenosis risk and improve safety profiles. Leading companies such as Medtronic, Boston Scientific, and Abbott are driving innovation and launching advanced products to address evolving clinical needs. With a growing demand for minimally invasive procedures and enhanced treatment outcomes, the balloon-expandable stents market is expected to witness steady growth in the coming years.
